Identification of therapeutic target genes for age-related hearing loss through systematic genome-wide mendelian randomization of druggable genes
Background: Age-related hearing loss (ARHL) is a common sensory disorder with significant public health implications. However, few effective treatment options are available. Mendelian randomization (MR) has been used to repurpose existing drugs and identify new therapeutic targets. Therefore, we per...
Saved in:
Main Authors: | Kun Zhang, Bo Hou, Tao Yan, Ruru Qiao, Peng Qu, Xinbo Xu, Hanbing Zhang |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2025-02-01
|
Series: | Experimental Gerontology |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S053155652500004X |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Identification of biomarkers for chronic lymphocytic leukemia risk: a proteome-wide Mendelian randomization study
by: Changyu Jin, et al.
Published: (2025-01-01) -
Exploring the role of circulating proteins in multiple myeloma risk: a Mendelian randomization study
by: Matthew A. Lee, et al.
Published: (2025-01-01) -
Causal associations between osteoporosis and HBV infection across Asian and European populations: evidence from Mendelian randomization and colocalization analysis
by: Zhengnan Li, et al.
Published: (2025-01-01) -
Assessing inflammatory protein factors in inflammatory bowel Disease using multivariable mendelian randomization
by: Qiang Su, et al.
Published: (2025-01-01) -
Mapping chromatin remodelling in glioblastoma identifies epigenetic regulation of key molecular pathways and novel druggable targets
by: Claire Vinel, et al.
Published: (2025-02-01)